Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-22 Purchase | 2023-12-27 09:00 am | Iterum Therapeutics plc | ITRM | Dunne Michael W. Director | 25,000 | $1.4 | $35,000 | 113,754 (Direct) | View |
| 2023-12-18 Purchase | 2023-12-19 4:15 pm | Iterum Therapeutics plc | ITRM | Dunne Michael W. Director | 10,000 | $1.8442 | $18,442 | 88,754 (Direct) | View |
| 2023-11-22 Purchase | 2023-11-27 5:00 pm | Iterum Therapeutics plc | ITRM | Dunne Michael W. Director | 20,000 | $2.0345 | $40,690 | 78,754 (Direct) | View |
| 2023-11-20 Purchase | 2023-11-20 5:00 pm | Iterum Therapeutics plc | ITRM | Fishman Corey N. Chief Executive Officer | 10,000 | $1.5863 | $15,863 | 54,449 (Direct) | View |
| 2022-12-02 Sale | 2022-12-05 5:00 pm | Iterum Therapeutics plc | ITRM | Puttagunta Sailaja Chief Medical Officer | 3,365 | $1.32 | $4,442 | 29,968 (Direct) | View |
| 2022-09-16 Sale | 2022-09-20 6:00 pm | Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director | 37,246 | $1.8238 | $67,930 | 410 (Indirect Direct) | View |
| 2022-09-13 Sale | 2022-09-15 5:36 pm | Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director | 45,000 | $2.0855 | $93,846 | 37,656 (Indirect Direct) | View |
| 2022-09-08 Sale | 2022-09-12 9:01 pm | Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director | 33,298 | $2.3065 | $76,803 | 82,656 (Indirect Direct) | View |
| 2022-09-07 Purchase | 2022-09-09 6:00 pm | Iterum Therapeutics plc | ITRM | Dunne Michael W. Director | 10,000 | $2.22 | $22,200 | 35,576 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-06 Exercise | 2024-08-12 09:00 am | 2024-07-22 2024-08-06 | Iterum Therapeutics plc | ITRM | Dunne Michael W. Director | 424,988 | $0 | 432,495 (Direct) | View |
| 2024-08-06 Exercise | 2024-08-12 09:00 am | 2024-07-22 2024-08-06 | Iterum Therapeutics plc | ITRM | Fishman Corey N. Chief Executive Officer | 330,452 | $0 | 302,288 (Direct) | View |
| 2024-08-06 Exercise | 2024-08-12 09:00 am | 2024-07-22 2024-08-06 | Iterum Therapeutics plc | ITRM | HUNT RONALD Director | 991,736 | $0 | 586,990 (Indirect) | View |
| 2023-12-01 Tax Withholding | 2023-12-04 5:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Puttagunta Sailaja Chief Medical Officer | 2,933 | $2.12 | 27,035 (Direct) | View |
| 2023-12-01 Exercise | 2023-12-04 5:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Puttagunta Sailaja Chief Medical Officer | 8,333 | $0 | 27,035 (Direct) | View |
| 2023-12-01 Option Award | 2023-12-04 5:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Puttagunta Sailaja Chief Medical Officer | 8,333 | $0 | 27,035 (Direct) | View |
| 2023-10-01 Exercise | 2023-10-02 09:22 am | N/A N/A | Iterum Therapeutics plc | ITRM | HUNT RONALD Director | 5,479 | $0 | 111,432 (Direct) | View |
| 2023-10-01 Exercise | 2023-10-02 09:20 am | N/A N/A | Iterum Therapeutics plc | ITRM | Dunne Michael W. Director | 3,487 | $0 | 58,754 (Direct) | View |
| 2023-07-01 Exercise | 2023-07-03 08:00 am | N/A N/A | Iterum Therapeutics plc | ITRM | Dunne Michael W. Director | 1,779 | $0 | 55,267 (Direct) | View |
| 2023-07-01 Exercise | 2023-07-03 08:00 am | N/A N/A | Iterum Therapeutics plc | ITRM | HUNT RONALD Director | 2,796 | $0 | 105,953 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-15 5:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Hecht Beth Director | 15,853 | $0 | 18,839 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-15 5:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Dunne Michael W. Director | 15,853 | $0 | 53,488 (Direct) | View |
| 2023-06-15 Exercise | 2023-06-15 5:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Chin Mark Director | 15,853 | $0 | 18,306 (Direct) | View |
| 2023-04-01 Exercise(A) | 2023-06-05 08:00 am | N/A N/A | Iterum Therapeutics plc | ITRM | Dunne Michael W. Director | 1,299 | $0 | 37,635 (Direct) | View |
| 2023-04-01 Exercise | 2023-04-03 8:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | HUNT RONALD Director | 2,041 | $0 | 6,071 (Direct) | View |
| 2023-03-31 Option Award | 2023-04-03 8:00 pm | N/A 2033-03-30 | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-03-31 Option Award | 2023-04-03 8:00 pm | N/A 2033-03-30 | Iterum Therapeutics plc | ITRM | Puttagunta Sailaja Chief Medical Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-04-01 Exercise | 2023-04-03 8:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Dunne Michael W. Director | 1,299 | $0 | 37,636 (Direct) | View |
| 2023-03-31 Option Award | 2023-04-03 8:00 pm | N/A 2033-03-30 | Iterum Therapeutics plc | ITRM | Fishman Corey N. Chief Executive Officer | 275,000 | $0 | 275,000 (Direct) | View |
| 2023-03-11 Tax Withholding | 2023-03-14 6:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 2,883 | $0.96 | 8,135 (Direct) | View |
| 2023-03-11 Exercise | 2023-03-14 6:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 6,666 | $0 | 8,135 (Direct) | View |
| 2023-03-11 Option Award | 2023-03-14 6:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 6,666 | $0 | 8,135 (Direct) | View |
| 2023-03-11 Tax Withholding | 2023-03-14 6:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Fishman Corey N. Chief Executive Officer | 5,683 | $0.96 | 44,449 (Direct) | View |
| 2023-03-11 Exercise | 2023-03-14 6:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Fishman Corey N. Chief Executive Officer | 14,333 | $0 | 44,449 (Direct) | View |
| 2023-03-11 Option Award | 2023-03-14 6:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Fishman Corey N. Chief Executive Officer | 14,333 | $0 | 44,449 (Direct) | View |
| 2023-01-01 Exercise | 2023-01-04 6:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Dunne Michael W. Director | 761 | $0 | 36,337 (Direct) | View |
| 2023-01-01 Exercise | 2023-01-04 6:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | HUNT RONALD Director | 1,197 | $0 | 101,116 (Direct) | View |
| 2022-12-23 Option Award | 2022-12-28 9:00 pm | N/A 2032-12-22 | Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director | 29,125 | $0.81 | 29,125 (Direct) | View |
| 2022-12-23 Option Award | 2022-12-28 9:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | HUNT RONALD Director | 5,479 | $0 | 5,479 (Direct) | View |
| 2022-12-23 Option Award | 2022-12-28 9:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Dunne Michael W. Director | 3,487 | $0 | 3,487 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-05 5:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Puttagunta Sailaja Chief Medical Officer | 8,334 | $0 | 29,968 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 5:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Puttagunta Sailaja Chief Medical Officer | 8,334 | $0 | 29,968 (Direct) | View |
| 2022-09-25 Option Award | 2022-09-28 06:12 am | N/A 2032-09-24 | Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director | 14,838 | $1.59 | 14,838 (Direct) | View |
| 2022-09-25 Option Award | 2022-09-27 9:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Dunne Michael W. Director | 1,779 | $0 | 1,779 (Direct) | View |
| 2022-09-25 Option Award | 2022-09-27 9:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | HUNT RONALD Director | 2,796 | $0 | 2,796 (Direct) | View |
| 2022-06-25 Option Award | 2022-06-28 9:00 pm | N/A 2032-06-24 | Iterum Therapeutics plc | ITRM | Ahrens Brenton Karl Director | 113,276 | $0 | 113,276 (Direct) | View |
| 2022-06-25 Option Award | 2022-06-28 9:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | HUNT RONALD Director | 30,623 | $0 | 30,623 (Direct) | View |
| 2022-06-25 Option Award | 2022-06-28 9:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Dunne Michael W. Director | 19,488 | $0 | 19,488 (Direct) | View |